Company: TVRD
Filing Date: 2025-05-30
Form Type: S-1
Source: 0001104659-25-054853
Chunk: 398

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-05-30
Form: S-1
Chunk 398
---
4 and 2023, accrued interest receivables on our available-for-sale debt securities were $62and $139, respectively.
F-73

CARA THERAPEUTICS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (amounts in thousands, except share and per share data)

4.Accumulated Other Comprehensive (Loss) Income

The following table summarizes the changes in accumulated other comprehensive (loss) income, net of tax, from unrealized gains (losses) on available-for-sale marketable securities, the Company’s only component of accumulated other comprehensive (loss) income, for the years ended December 31, 2024, 2023 and 2022.

| ​                                                             
 ​                                                             
 ​                                                             
 ​                                                             | ​ 
 ​ 
 ​ | ​                   
 Total Accumulated   
 Other Comprehensive 
 Income (Loss)       |      ​ |
|:--------------------------------------------------------------|:--|:--------------------|-------:|
| Balance, December 31, 2021                                    | ​ | $                   |   -358 |
| Other comprehensive loss before reclassifications             | ​ |                     | -1,314 |
| Amount reclassified from accumulated other comprehensive loss | ​ |                     |      — |
| Net current period other comprehensive loss                   | ​ |                     | -1,314 |
| Balance, December 31, 2022                                    | ​ |                     | -1,672 |
| Other comprehensive income before reclassifications           | ​ |                     |  1,412 |
| Amount reclassified from accumulated other comprehensive loss | ​ |                     |      — |
| Net current period other comprehensive income                 | ​ |                     |  1,412 |
| Balance, December 31, 2023                                    | ​ | $                   |   -260 |
| Other comprehensive income before reclassifications           | ​ |                     |    260 |
| Amount reclassified from accumulated other comprehensive loss | ​ |                     |      — |
| Net current period other comprehensive income                 | ​ |                     |    260 |
| Balance, December 31, 2024                                    | ​ | $                   |      — |

Amounts reclassified out of accumulated other comprehensive (loss) income into net loss are determined by specific identification. There were reclassifications out of accumulated other comprehensive (loss) income and into net loss for the years ended December 31, 2024, 2023, and 2022.

5.Inventory, net

Inventories consist of the